Effect of lifestyle intervention on the reproductive endocrine profile in women with polycystic ovarian syndrome: a systematic review and meta-analysis
- PMID: 24488490
- PMCID: PMC3938041
- DOI: 10.1530/EC-14-0010
Effect of lifestyle intervention on the reproductive endocrine profile in women with polycystic ovarian syndrome: a systematic review and meta-analysis
Abstract
Polycystic ovarian syndrome (PCOS) affects 18-22% of women at reproductive age. We conducted a systematic review and meta-analysis evaluating the expected benefits of lifestyle (exercise plus diet) interventions on the reproductive endocrine profile in women with PCOS. Potential studies were identified by systematically searching PubMed, CINAHL and the Cochrane Controlled Trials Registry (1966-April 30, 2013) systematically using key concepts of PCOS. Significant improvements were seen in women receiving lifestyle intervention vs usual care in follicle-stimulating hormone (FSH) levels, mean difference (MD) 0.39 IU/l (95% CI 0.09 to 0.70, P=0.01), sex hormone-binding globulin (SHBG) levels, MD 2.37 nmol/l (95% CI 1.27 to 3.47, P<0.0001), total testosterone levels, MD -0.13 nmol/l (95% CI -0.22 to -0.03, P=0.008), androstenedione levels, MD -0.09 ng/dl (95% CI -0.15 to -0.03, P=0.005), free androgen index (FAI) levels, MD -1.64 (95% CI -2.94 to -0.35, P=0.01) and Ferriman-Gallwey (FG) score, MD -1.01 (95% CI -1.54 to -0.48, P=0.0002). Significant improvements were also observed in women who received exercise-alone intervention vs usual care in FSH levels, MD 0.42 IU/l (95% CI 0.11 to 0.73, P=0.009), SHBG levels, MD 3.42 nmol/l (95% CI 0.11 to 6.73, P=0.04), total testosterone levels, MD -0.16 nmol/l (95% CI -0.29 to -0.04, P=0.01), androstenedione levels, MD -0.09 ng/dl (95% CI -0.16 to -0.03, P=0.004) and FG score, MD -1.13 (95% CI -1.88 to -0.38, P=0.003). Our analyses suggest that lifestyle (diet and exercise) intervention improves levels of FSH, SHBG, total testosterone, androstenedione and FAI, and FG score in women with PCOS.
Keywords: exercise; female reproduction; follicle-stimulating hormone; insulin resistance; luteinizing hormone; polycystic ovarian syndrome.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3938041/bin/ec-03-36-g001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3938041/bin/ec-03-36-g002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3938041/bin/ec-03-36-g003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3938041/bin/ec-03-36-g004.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3938041/bin/ec-03-36-g005.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3938041/bin/ec-03-36-g006.gif)
![Figure 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3938041/bin/ec-03-36-g007.gif)
![Figure 8](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3938041/bin/ec-03-36-g008.gif)
![Figure 9](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3938041/bin/ec-03-36-g009.gif)
![Figure 10](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3938041/bin/ec-03-36-g010.gif)
![Figure 11](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3938041/bin/ec-03-36-g011.gif)
![Figure 12](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3938041/bin/ec-03-36-g012.gif)
Similar articles
-
Lifestyle changes in women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007506. doi: 10.1002/14651858.CD007506.pub2. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2011 Jul 06;(7):CD007506. doi: 10.1002/14651858.CD007506.pub3. PMID: 21328294 Updated. Review.
-
The Effect of Lifestyle Intervention on Body Composition, Glycemic Control, and Cardiorespiratory Fitness in Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis.Int J Sport Nutr Exerc Metab. 2015 Dec;25(6):533-40. doi: 10.1123/ijsnem.2013-0232. Epub 2014 Mar 25. Int J Sport Nutr Exerc Metab. 2015. PMID: 24668721 Review.
-
Lifestyle changes in women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2011 Jul 6;(7):CD007506. doi: 10.1002/14651858.CD007506.pub3. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2019 Mar 28;3:CD007506. doi: 10.1002/14651858.CD007506.pub4. PMID: 21735412 Updated. Review.
-
The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents.J Clin Med. 2020 Jun 11;9(6):1831. doi: 10.3390/jcm9061831. J Clin Med. 2020. PMID: 32545404 Free PMC article.
-
A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.JAMA Dermatol. 2016 Sep 1;152(9):986-91. doi: 10.1001/jamadermatol.2016.1776. JAMA Dermatol. 2016. PMID: 27304785
Cited by
-
Vigorous vs. moderate exercise to improve glucose metabolism in inactive women with polycystic ovary syndrome and insulin resistance: a pilot randomized controlled trial of two home-based exercise routines.F S Rep. 2023 Dec 22;5(1):80-86. doi: 10.1016/j.xfre.2023.12.004. eCollection 2024 Mar. F S Rep. 2023. PMID: 38524210 Free PMC article.
-
Reduction in the Free Androgen Index in Overweight Women After Sixty Days of a Low Glycemic Diet.Exp Clin Endocrinol Diabetes. 2024 Jan;132(1):6-14. doi: 10.1055/a-2201-8618. Epub 2024 Jan 18. Exp Clin Endocrinol Diabetes. 2024. PMID: 38237611 Free PMC article.
-
Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?J Endocrinol Invest. 2023 Sep;46(9):1761-1774. doi: 10.1007/s40618-023-02084-6. Epub 2023 Apr 24. J Endocrinol Invest. 2023. PMID: 37093453 Free PMC article. Review.
-
Lifestyle management in polycystic ovary syndrome - beyond diet and physical activity.BMC Endocr Disord. 2023 Jan 16;23(1):14. doi: 10.1186/s12902-022-01208-y. BMC Endocr Disord. 2023. PMID: 36647089 Free PMC article. Review.
-
A comparison of the effects of cinnamon, ginger, and metformin consumption on metabolic health, anthropometric indices, and sexual hormone levels in women with poly cystic ovary syndrome: A randomized double-blinded placebo-controlled clinical trial.Front Nutr. 2022 Nov 29;9:1071515. doi: 10.3389/fnut.2022.1071515. eCollection 2022. Front Nutr. 2022. PMID: 36523331 Free PMC article.
References
-
- Stein I, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. American Journal of Obstetrics and Gynecology. 1935;29:181–191.
-
- Jedel E, Labrie F, Odén A, Holm G, Nilsson L, Janson PO, Lind AK, Ohlsson C, Stener-Victorin E. Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial. American Journal of Physiology. Endocrinology and Metabolism. 2011;300:E37–E45. doi: 10.1152/ajpendo.00495.2010. - DOI - PubMed
-
- Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism. 2008;93:3373–3380. doi: 10.1210/jc.2008-0751. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous